Both chlorothiazide and parenteral mercurial diuretics have an antihypertensive as well as a natriuretic action. Previous observations have suggested that the antihypertensive effect is not due solely to sodium depletion. This paper expands these observations on a larger group of normotensive and hypertensive subjects and presents new studies on the effects of fluorohydrocortisone and SC-8109 (a "steroidal antagonist"), upon the sodium excretion and blood pressure of hypertensive patients during treatment with one of the diuretics.
Both chlorothiazide and parenteral mercurial diuretics have an antihypertensive as well as a natriuretic action. Previous observations have suggested that the antihypertensive effect is not due solely to sodium depletion. This paper expands these observations on a larger group of normotensive and hypertensive subjects and presents new studies on the effects of fluorohydrocortisone and SC-8109 (a "steroidal antagonist"), upon the sodium excretion and blood pressure of hypertensive patients during treatment with one of the diuretics.
ORAL chlorothiazide has been shown by a number of workers to be effective as an antihypertensive as well as a diuretic agent.1-'5 Parenteral mercurial diuretics likewise have been found to exert a hypotensive action in hypertensive subjects with or without complicating heart failure.12' 13, 16 Although the mode of action of these diuretic agents on the blood pressure has not been clearly determined, clinical and laboratory observations have suggested that the antihypertensive effects of chlorothiazide may not be due solely to sodium depletion but might result in part from some other action to the drug.9' 12, 13 The current study presents further observations on the relationship between the saluretic and hypotensive actions of chlorothiazide and of the mercurial diuretics.
MATERIAL AND METHODS
Twenty ambulatory normal subjects,* most of whom were medical students, were given oral ehlorothiazide after a 1-to 2-week control period. They were maintained on the drug during an unrestricted dietary salt intake for 30 days at a dose of 250 mg. of chlorothiazide 3 times a day. Observations of blood pressure and weight were recorded daily. Supported in part by a grant from the National Heart Institute, U. S. Public Health Service and from Merek Sharp and Dohme and Company, Inc.
*Fifteen of these subjects were previously reported. 13' 827 In addition, similar observations of blood pressure responses to the parenteral administration of chlorothiazide or of a mercurial diuretic were made in 15 normal and in 15 hypertensive ambulatory subjects without complicating heart failure. The hypertension was of the "essential" type except in 3 subjects who had an antecedant history suggesting either pyelonephritis or renal vascular disease. After preliminary control observations of blood pressure were obtained every 15 to 20 minutes for 3 hours, chlorothiazide was given intravenously in a dose of 1.0 Gm. over a period of 60 to 90 seconds. In the same or other individuals mercaptomerin or meralluride was injected subcutaneously or intravenously in a 2-ml. dose. After the administration of the diuretic, blood pressure was determined at intervals of 15 to 30 minutes for the first 8 hours and thereafter 8 times daily for the next 4 to 5 days. Weight was recorded before and after the administration of the diuretic. Urine was collected for the 24 hours following the injection.
Similar renal excretory and blood pressure studies were made of the effects of chlorothiazide or of a mercurial diuretic in 8 hypertensive subjects during known dietary salt intakes and following the administration of 9-a-fluorohydrocortisone or of SC-8109,* a steroidal lactone. Seven of these subjects had essential hypertension and 1, C.L., had hypertension associated with occlusion of the right renal artery. Two subjects, C.L. and E.M., had been subjected to splanchnicectomy (Smithwick) more than 1 year prior to the present study without having a marked reduction in blood pressure. All subjects had a sustained elevation of the blood pressure with grade 2 retinopathy but without complicating congestive heart failure or nitrogen retention. For at least 6 weeks prior to the study HO8HLD ANDER, CHOBANIAN, WAICLINS One potassium balance study and 9 sodium balance studies were carried out over a period of 16 to 32 days. In order to avoid the possible effect of hospitalization and bed rest on the blood pressure, all of these subjects with the exception of C.L., H.L., and E.M. were studied while ambulatory. Daily meals, which contained a total of 9 mEq. of sodium, were prepared by the dietary department and given in the hospital. Sodium The hypertensive subjects who had a reduction in blood pressure following the administration of the mercurial diuretics also had thiazide administration. The losses of body potassium occlurred gradually over a period of 5) davs. As chlorothiazide was continued, the cumulative negative sodium balance rose toward normal, 62 to 81 inEq., but without an accoilnlallying increase in the blood pressure. When (hliorothiazide was withdrawn and simultaneously the daily intake of sodium reduced to 9 mnEq. on the twelfth metabolic day, the blood pressure did not rise but renmained at the previous level of reduction. I)uring this period the negative sodium balance previously caused by chlorothiazide persisted but the cumlulative negative balance of potassium disappeared.
Followinlg the reinstitution of chlorothiazide during the sodium restricted diet on the nineteenth metabolic day additional losses of body sodium and potassium occurred without a further reduction in blood pressure.
In general, changes in serum postassium varied in the same direction as those in the potassium balance, whereas changes in serum sodium were slight and did not necessarily accompany those ill the cumulative sodium balance.
After withdrawing chlorothiazide and increasing the daily sodium intake to 145 mEq., the blood pressure increased to the pretreatment level while sodium and potassium balances returned to or above control values.
Balance Study 2. The effects of intravenous chlorothiazide on the blood pressure and sodium balance in subject, M.L., with essential hypertension are shown in table 2.
During a reduced sodium intake of 9 mEq. per day a cumulative negative sodium balance of 138 mEq. resulted without an appreciable change in the blood pressure. An intravenous injection of 1 Gm. of chlorothiazide on the sixth metabolic day was followed by a further sodium loss of 58 mEq. as well as a decrease in blood pressure. The reduction in blood pressure, which occurred 18 hours after the injection of chlorothiazide, persisted for 6 days along with a cumulative negative sodium balance of 149 to 196 mEq. during continued sodium restriction. After the daily sodium intake was increased to 145 mEq. on the thirteenth metabolic day, the sodium balance returned to and above control values while the blood pressure rose to pretreatment levels.
Balance Study 3. The effects of a parenteral mercurial diuretic on the blood pressure and sodium balance in subject, E.A., with essential hypertension are illustrated in figure 2.
After the sodium intake was restricted to 9 mEq. per day a cumulative negative sodium balance of 146 mEq. developed without a striking change in blood pressure. On the fifth metabolic day, 20 hours following the intravenous injection of meralluride, a marked reduction in blood pressure occurred together with an increase of 63 mEq. in the cumulative negative sodium balance. The hypotensive effect of meralluride like that of chlorothiazide persisted during the maintenance of sodium restriction and a negative sodium balance. However, when the daily intake of sodium was increased to 145 mEq. on the twelfth metabolic day, both the blood pressure and sodium balance returned to or above the control levels.
In repeating the same type of experiment in subject R.D. with essential hypertension (table 3) similar results were obtained. The hypotensive effect of intravenous mercaptomerin was associated with a cumulative negative sodium balance of 169 mEq. It persisted until the negative sodium balance, which was maintained by sodium restriction, reverted to and above control values following an increase of the sodium intake to 145 mEq. per day.
Balance Study 4. The effects of chlorothiazide and a mercurial diuretic on the blood pressure and sodium balance in a splanchnicectomized subject, C.Lj., with renal hypertension are shown in figure 3 .
During a reduced daily sodium intake of 77 mEq. the maximal reductions in blood pressure and losses of sodium occurred during the first 2 days of chlorothiazide treatment. However, the initial fall in blood pressure of 25/20 mm. Hg appeared 4 hours after the start of chlorothiazide and was associated with a net sodium loss of 48 mEq. As chlorothiazide was continued, the cumulative negative sodium balance moderated from 226 to 165 mEq. but then returned toward the greater negative values. During these changes in sodium balance the hypotensive effect of chlorothiazide was not strikingly altered.
When chlorothiazide was withdrawn while the daily sodium intake was simultaneously reduced to 9 mEq. per day on the sixteenth   FIG. 1 Top. Study 1: Oral chlorothiazide in a subject with essential hypertension. In each balance figure, the blood pressure which is plotted daily is the average value of 6 or more determinations. The daily intake of sodium or potassium is measured upward from the zero baseline. The cumulative negative sodium or potassium balance is shown by a hatched or cross-hatched area below the zero baseline. The cumulative positive sodium or potassium balance is plotted above the zero baseline. Weight in kilograms is shown at the beginning of each balance day. During the period of negative sodium balance there were no striking reductions in the creatinine clearance or in the serum potassium although there was a slight reduction in the serum sodium.
After all drugs were withdrawn and the daily intake of sodium was increased to 180 mEq., the blood pressure increased to the pretreatment values and the sodium balance returned to and above the control levels.
In subject E.M. with essential hypertension and previous splanchnicectomy (table 4 fig. 5 ) with essential hypertension. In these subjects the hypotensive action of chlorothiazide after the addition of fluorohydrocortisone also persisted in the absence of a negative sodium balance. Although the blood pressure in subject R.D. rose as body sodium increased to and above control values following the administration of fluorohydrocortisone, it did not return to the pretreatment levels. In both of these subjects, as in subject L.K., the sodium retention following the administration of fluorohydrocortisone during chlorothiazide therapy was not accompanied by a noticeable increase in weight.
Balance Study 6. The effects of SC-8109, 3-(3-oxo-17 B-hydroxy-19-nor-4-androsten-17-ayl) propionie acid lactone, on the diuretic and hypotensive actions of chlorothiazide in subject R.D. with essential hypertension are shown in figure 5 .
The effects of SC-8109, a "steroidal antagonist, '18, 19 uretic effect of chlorothiazide and for the excess retention of sodium after the withdrawal of chlorothiazide.
On the eleventh metabolic day SC-8109 was added to chlorothiazide during a daily intake of 77 mEq. of sodium. At this time the net loss of sodium was 161 mEq. and no further reductions in body sodium and blood pressure were being produced by ehlorothiazide. SC-8109 given in a daily dose of 750 mu. in combination with chlorothiazide for 4 days produced an additional loss of 181 mEq. of sodium and a decrease in blood pressure of 35/10 mm. Hg. During this period there was a slight increase in serum potassium without an appreciable change in serum sodium. After withdrawing SC-8109 and increasing the daily intake of sodium to 163 mEq. on the fifteenth metabolic day while continuing chlorothiazide, the cumulative negative sodium balance decreased and the blood pressure increased to the levels that existed before the administration of SC-8109. The remaining part of the experiment was described in study 5 .
DiscussIoN
Chlorothiazide or parenteral mercurial diuretics apparently exerted a hypotensive action in arterial hypertension during a daily sodium intake of 9 mEq. to 214 mEq. The reductions in blood pressure following the administration of these agents were usually associated with a cumulative negative sodium balance of 150 to 200 mEq. but occurred in splanchnicectomized hypertensive subjects during a net sodium loss as little as 50 mEq. The continued reduction in blood pressure after withdrawing the diuretic agents and restricting sodium intake to 9 mEq. per day was also associated with a continued negative 
SUMMARY
During a controlled sodium intake of 9 to 214 mEq. per day, chlorothiazide and parenteral mercurial diuretics produced a hypotensive effect in hypertensive patients that was associated with a negative sodium and potassium balance. The hypotensive action of these compounds, which was maintained after their withdrawal by restricting sodium intake, was also associated with a negative sodium but not a negative potassium balance. However, experiments in which fluorohydrocortisone was added to chlorothiazide indicated that chlorothiazide is capable of maintaining a lowered blood pressure in the presence of an unreduced body sodium. The natriuretic and hypotensive effects of chlorothiazide were increased by the addition of SC-8109, a steroidal lactone, to chlorothiazide. The 
